A First-in-Human Study of QY211 Gel in Adult Subjects
Status:
Recruiting
Trial end date:
2024-10-23
Target enrollment:
Participant gender:
Summary
This is a phase Ia/Ib,Randomized, Double-Blind, Placebo-Controlled Phase 1 Clinical Study to
Evaluate the Safety, Tolerability, Pharmacokinetic Characteristics, and Preliminary Efficacy
of Single and Multiple Topical Doses of QY211 Gel in Healthy Chinese Subjects and Patients
with Mild to Moderate Atopic Dermatitis